All In MedTech

Device Trial Radar · NCT05071963

INSPIRE Pipeline™ Shield Post Approval Study

Neurovascular Product Surveillance Registry (INSPIRE) Pipeline™ Flex Embolization Device With Shield Technology™ Post Approval Study (PAS)

Last checked: Nov 19, 2026Latest source record: Aug 10, 2026 (this record)Source: ClinicalTrials.govMethods & limitations

Active, not recruiting

Status

Active, not recruiting

Enrollment

246

Actual

Start

Dec 20, 2021

Primary completion

Jan 2027

Study completion Apr 2028

Sponsor

Sponsor type
Industry
First posted
Oct 8, 2021

More device trials from this sponsor

Design

Study type
Observational
FDA-regulated device
Yes
Who can join
All sexes, from 22 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

The purpose of the Pipeline™ Flex Embolization Device with Shield Technology™ Post Approval Study (PAS) ("Pipeline™ Shield PAS") is to collect on-label use data in patients undergoing treatment for intracranial aneurysms (IA) using the Pipeline™ Flex Embolization Device with Shield Technology™ ("Pipeline™ Shield Device") in a real-world post approval setting within the United States.

Conditions

  • Intracranial Aneurysm

Interventions

  • Treatment of Intracranial AneurysmsDevice

    Embolization of aneurysms using the Pipeline™ Flex Embolization Device with Shield Technology™

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Incidence of the composite outcome (Occlusion of the target aneurysm, Significant parent artery stenosis, Retreatment of the target aneurysm) at 1 year post-procedure.Time frame: 1 year

Locations

16 sites in 1 country. Site status is shown where the registry gives one.

  • University of Alabama at Birmingham

    Birmingham, Alabama

  • Yale New Haven Hospital

    New Haven, Connecticut

  • Baptist Medical Center Jacksonville

    Jacksonville, Florida

13 more study sites with a free account

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.